ArrePath Announces $20 Million Seed Financing to Advance its Machine Learning-based Platform for Discovery of Novel Anti-infectives Addressing Antimicrobial Resistance

ArrePath Announces $20 Million Seed Financing to Advance its Machine Learning-based Platform for Discovery of Novel Anti-infectives Addressing Antimicrobial Resistance - read this article along with other careers information, tips and advice on BioSpace

Related Keywords

Boston ,Massachusetts ,United States ,Lloyd Payne ,Viva Bioinnovator ,Fei Shen ,Zemer Gitai ,Impact Fund Scientific Selection Board ,Action Fund Scientific Advisory Board ,Boehringer Ingelheim Venture Fund United States ,Twitter ,World Health Organization ,Princeton University ,Us Centers For Disease ,Boehringer Ingelheim Venture Fund ,Insight Partners ,Innospark Ventures ,Arimed Capital ,Arrepath President ,Business Wire ,Fund Scientific Selection Board ,Fund Scientific Advisory Board ,Executive Vice President ,Artificial Intelligence ,Machine Learning Based ,Managing Director ,Boehringer Ingelheim Venture Fund United ,Edwin Grant Conklin Professor ,Disease Control ,United Kingdom Commissionedo Neill Review ,Resume ,Careers ,Rrepath Announces 20 Million Seed Financing To Advance Its Machine Learning Based Platform For Discovery Of Novel Anti Infectives Addressing Antimicrobial Resistance ,Iospace ,Advice ,